ISHARES TR - GENOMICS IMMUN (IDNA)

Historical Holders from Q1 2019 to Q3 2025

Symbol
IDNA
Type / Class
Equity / GENOMICS IMMUN
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
2,066,161
Holdings value
$48,778,790
% of all portfolios
0%
Number of holders
50
Number of buys
25
Number of sells
-17
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,066,161 $48,778,790 -$1,713,843 $23.61 50
2025 Q2 2,149,205 $44,080,900 +$15,101 $20.51 47
2025 Q1 2,165,537 $44,367,995 -$285,218 $20.49 48
2024 Q4 2,157,546 $48,835,109 +$10,354,691 $22.63 59
2024 Q3 1,680,314 $41,340,128 -$5,490,533 $24.61 53
2024 Q2 1,950,035 $45,091,438 +$1,992,116 $23.12 62
2024 Q1 1,861,562 $44,794,981 -$3,697,512 $24.08 62
2023 Q4 1,991,349 $45,833,877 +$5,167,614 $23.01 65
2023 Q3 1,765,501 $35,851,749 -$5,851,664 $20.35 64
2023 Q2 2,047,811 $47,862,054 +$556,758 $23.35 66
2023 Q1 2,026,627 $47,189,243 +$3,402,408 $23.27 73
2022 Q4 1,839,513 $46,236,774 +$1,003,483 $25.17 75
2022 Q3 1,775,633 $46,871,606 -$4,662,042 $26.39 64
2022 Q2 1,911,375 $55,225,760 -$8,606,465 $28.9 65
2022 Q1 2,127,485 $73,293,979 -$22,100,891 $34.45 80
2021 Q4 2,600,566 $115,305,922 +$23,169,696 $43.81 102
2021 Q3 2,042,497 $103,546,388 +$8,436,124 $50.71 87
2021 Q2 1,886,983 $98,179,468 +$1,107,608 $52.03 82
2021 Q1 1,869,472 $90,061,576 +$20,195,651 $45.71 77
2020 Q4 1,425,998 $70,061,995 +$15,568,071 $45.94 63
2020 Q3 1,114,144 $47,204,226 +$4,596,058 $38.96 47
2020 Q2 616,851 $23,420,769 +$13,527,542 $37.97 34
2020 Q1 538,038 $14,458,374 -$5,314,526 $26.87 10
2019 Q4 742,636 $22,333,000 -$2,519,707 $30 5
2019 Q3 826,968 $20,452,000 +$14,310,109 $29.41 3
2019 Q2 239,381 $6,677,000 +$6,318,000 $27.17 4
2019 Q1 6,900 $359,000 $52.03 1